bpc-157 regulatory status fda approval 3 FOR 3. An advisory committee has now voted 8–6, with one abstention, to recommend BPC-157, KPV and TB-500 for inclusion on the 503A Bulks List. This is not FDA FDA Peptide Reclassification 2026: What
FDA Peptide Reclassification 2026: What It Means for Providers Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for BPC 157 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank FDA's Overreach on Compounded Peptides FDA to review 7 popular peptides touted for weight loss, healing and longevity
Pay in 4 interest-free payments of $6.75 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12


